NYSE · CIK 0001701478
AZTR Azitra, Inc.
Insider trading from SEC Form 4. Last filing Jun 18, 2026.
In brief
Azitra, Inc. (AZTR) has 10 SEC Form 4 filings on file from 5 insiders, the latest filed on Jun 18, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Azitra, Inc., scored.
Transactions
Every row filed, 13 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Francisco D. Salva President and CEO | CConversion Common Stock | +4,064,050 | - | - | 4,086,291 | Jun 18, 2026 |
| Jun 16, 2026 | Francisco D. Salva President and CEO | CConversion Series A Convertible Non-Redeemable Preferred Stockderivative | -500 | - | - | 0 | Jun 18, 2026 |
| Apr 20, 2026 | Travis Whitfill Chief Operating Officer | AGrant or award Stock Options (Right To Buy)derivative | +64,300 | $0.00 | $0 | 64,300 | Apr 22, 2026 |
| Apr 20, 2026 | Francisco D. Salva President and CEO | AGrant or award Stock Options (Right To Buy)derivative | +220,879 | $0.00 | $0 | 220,879 | Apr 22, 2026 |
| Apr 20, 2026 | Norm Staskey Chief Financial Officer | AGrant or award Stock Options (Right To Buy)derivative | +35,524 | $0.00 | $0 | 35,524 | Apr 22, 2026 |
| Mar 18, 2026 | Francisco D. Salva President and CEO | POpen-market purchase Series A Convertible Non-Redeemable Preferred Stockderivative | +500 | - | - | 500 | Mar 20, 2026 |
| Mar 18, 2026 | Francisco D. Salva President and CEO | POpen-market purchase Series B Warrantsderivative | +4,064,050 | - | - | 4,064,050 | Mar 20, 2026 |
| Mar 18, 2026 | Francisco D. Salva President and CEO | POpen-market purchase Series C Warrantsderivative | +4,064,050 | - | - | 4,064,050 | Mar 20, 2026 |
| Dec 19, 2025 | Barbara Ryan director | AGrant or award Stock Options (Right To Buy)derivative | +3,003 | $0.00 | $0 | 3,003 | Dec 22, 2025 |
| Dec 19, 2025 | Francisco D. Salva President and CEO | AGrant or award Stock Options (Right To Buy)derivative | +59,309 | $0.00 | $0 | 59,309 | Dec 22, 2025 |
| Dec 19, 2025 | John R. Schroer director | AGrant or award Stock Options (Right To Buy)derivative | +3,003 | $0.00 | $0 | 3,003 | Dec 22, 2025 |
| Dec 19, 2025 | Norm Staskey Chief Financial Officer | AGrant or award Stock Options (Right To Buy)derivative | +15,015 | $0.00 | $0 | 15,015 | Dec 22, 2025 |
| Dec 19, 2025 | Travis Whitfill Chief Operating Officer | AGrant or award Stock Options (Right To Buy)derivative | +23,724 | $0.00 | $0 | 23,724 | Dec 22, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Barbara Ryandirector
- Francisco D. SalvaPresident and CEO
- John R. Schroercfo, officer, director
- Norm StaskeyChief Financial Officer
- Travis WhitfillChief Operating Officer
Questions about AZTR
Answered from the filings on this page, as of the latest one.
Are insiders buying AZTR?
No. In the last 90 days no insider at Azitra, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade AZTR on the open market?
No open-market trade has been scored at Azitra, Inc.. The latest Form 4 on file was filed on Jun 18, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Azitra, Inc.?
5 people have filed a Form 4 at Azitra, Inc., among them Barbara Ryan (director), Francisco D. Salva (President and CEO), John R. Schroer (CFO and director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.